Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$2.5 - $5.19 $2.5 Million - $5.18 Million
-998,278 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$13.68 - $20.46 $3.89 Million - $5.82 Million
284,466 Added 39.85%
998,278 $16 Million
Q1 2020

May 14, 2020

BUY
$14.83 - $26.72 $391,289 - $705,007
26,385 Added 3.84%
713,812 $11.1 Million
Q4 2019

Feb 14, 2020

SELL
$9.77 - $24.6 $3.04 Million - $7.65 Million
-310,851 Reduced 31.14%
687,427 $16.9 Million
Q1 2019

May 14, 2019

BUY
$5.98 - $13.98 $376 - $880
63 Added 0.01%
998,278 $12.4 Million
Q4 2018

Feb 13, 2019

BUY
$5.22 - $10.44 $420,210 - $840,420
80,500 Added 8.77%
998,215 $6.15 Million
Q3 2018

Nov 13, 2018

SELL
$9.5 - $13.75 $218,215 - $315,837
-22,970 Reduced 2.44%
917,715 $9.73 Million
Q2 2018

Aug 14, 2018

SELL
$12.85 - $18.45 $740,070 - $1.06 Million
-57,593 Reduced 5.77%
940,685 $12.7 Million
Q4 2017

Feb 13, 2018

BUY
$11.55 - $20.1 $1.72 Million - $2.99 Million
148,585 Added 17.49%
998,278 $12.5 Million
Q3 2017

Nov 13, 2017

BUY
$12.7 - $19.25 $639,191 - $968,852
50,330 Added 6.3%
849,693 $16.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
799,363
799,363 $12.1 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Foresite Capital Management Iii, LLC Portfolio

Follow Foresite Capital Management Iii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.